199 related articles for article (PubMed ID: 20627767)
1. DNA methylation in pre-diagnostic serum samples of breast cancer cases: results of a nested case-control study.
Brooks JD; Cairns P; Shore RE; Klein CB; Wirgin I; Afanasyeva Y; Zeleniuch-Jacquotte A
Cancer Epidemiol; 2010 Dec; 34(6):717-23. PubMed ID: 20627767
[TBL] [Abstract][Full Text] [Related]
2. Detection of aberrant promoter methylation of GSTP1, RASSF1A, and RARβ2 in serum DNA of patients with breast cancer by a newly established one-step methylation-specific PCR assay.
Yamamoto N; Nakayama T; Kajita M; Miyake T; Iwamoto T; Kim SJ; Sakai A; Ishihara H; Tamaki Y; Noguchi S
Breast Cancer Res Treat; 2012 Feb; 132(1):165-73. PubMed ID: 21594664
[TBL] [Abstract][Full Text] [Related]
3. Detection of promoter methylation of tumor suppressor genes in serum DNA of breast cancer cases and benign breast disease controls.
Sturgeon SR; Balasubramanian R; Schairer C; Muss HB; Ziegler RG; Arcaro KF
Epigenetics; 2012 Nov; 7(11):1258-67. PubMed ID: 22986510
[TBL] [Abstract][Full Text] [Related]
4. Tumor suppressor gene promoter hypermethylation in serum of breast cancer patients.
Dulaimi E; Hillinck J; Ibanez de Caceres I; Al-Saleem T; Cairns P
Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6189-93. PubMed ID: 15448006
[TBL] [Abstract][Full Text] [Related]
5. Methylation Profiles of BRCA1, RASSF1A and GSTP1 in Vietnamese Women with Breast Cancer.
Vu TL; Nguyen TT; Doan VTH; Vo LTT
Asian Pac J Cancer Prev; 2018 Jul; 19(7):1887-1893. PubMed ID: 30049201
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypermethylation in benign breast epithelium in relation to predicted breast cancer risk.
Lewis CM; Cler LR; Bu DW; Zöchbauer-Müller S; Milchgrub S; Naftalis EZ; Leitch AM; Minna JD; Euhus DM
Clin Cancer Res; 2005 Jan; 11(1):166-72. PubMed ID: 15671542
[TBL] [Abstract][Full Text] [Related]
7. Promoter Methylation of BRCA1, DAPK1 and RASSF1A is Associated with Increased Mortality among Indian Women with Breast Cancer.
Yadav P; Masroor M; Nandi K; Kaza RCM; Jain SK; Khurana N; Saxena A
Asian Pac J Cancer Prev; 2018 Feb; 19(2):443-448. PubMed ID: 29480000
[TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation of RASSF1A in plasma DNA before breast cancer diagnosis in the Breast Cancer Family Registry.
Yazici H; Terry MB; Cho YH; Senie RT; Liao Y; Andrulis I; Santella RM
Cancer Epidemiol Biomarkers Prev; 2009 Oct; 18(10):2723-5. PubMed ID: 19755643
[TBL] [Abstract][Full Text] [Related]
9. Aberrant promoter hypermethylation and genomic hypomethylation in tumor, adjacent normal tissues and blood from breast cancer patients.
Cho YH; Yazici H; Wu HC; Terry MB; Gonzalez K; Qu M; Dalay N; Santella RM
Anticancer Res; 2010 Jul; 30(7):2489-96. PubMed ID: 20682973
[TBL] [Abstract][Full Text] [Related]
10. Quantitative assessment of DNA hypermethylation in the inflammatory and non-inflammatory breast cancer phenotypes.
Van der Auwera I; Bovie C; Svensson C; Limame R; Trinh XB; van Dam P; Van Laere SJ; Van Marck E; Vermeulen PB; Dirix LY
Cancer Biol Ther; 2009 Dec; 8(23):2252-9. PubMed ID: 19829046
[TBL] [Abstract][Full Text] [Related]
11. Promoter hypermethylation of the tumor-suppressor genes RASSF1A, GSTP1 and CDH1 in endometrial cancer.
Fiolka R; Zubor P; Janusicova V; Visnovsky J; Mendelova A; Kajo K; Lasabova Z; Plank L; Danko J
Oncol Rep; 2013 Dec; 30(6):2878-86. PubMed ID: 24068440
[TBL] [Abstract][Full Text] [Related]
12. Aberrant methylation of APC and RARβ2 genes in breast cancer patients.
Swellam M; Abdelmaksoud MD; Sayed Mahmoud M; Ramadan A; Abdel-Moneem W; Hefny MM
IUBMB Life; 2015 Jan; 67(1):61-8. PubMed ID: 25684670
[TBL] [Abstract][Full Text] [Related]
13. CpG island methylator phenotype of multigene in serum of sporadic breast carcinoma.
Jing F; Yuping W; Yong C; Jie L; Jun L; Xuanbing T; Lihua H
Tumour Biol; 2010 Aug; 31(4):321-31. PubMed ID: 20490964
[TBL] [Abstract][Full Text] [Related]
14. Methylated APC and GSTP1 genes in serum DNA correlate with the presence of circulating blood tumor cells and are associated with a more aggressive and advanced breast cancer disease.
Matuschek C; Bölke E; Lammering G; Gerber PA; Peiper M; Budach W; Taskin H; Prisack HB; Schieren G; Orth K; Bojar H
Eur J Med Res; 2010; 15(7):277-86. PubMed ID: 20696638
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of promoter hypermethylation of DNA repair genes in tumor and serum DNA in invasive ductal breast carcinoma patients.
Sharma G; Mirza S; Parshad R; Srivastava A; Gupta SD; Pandya P; Ralhan R
Life Sci; 2010 Jul; 87(3-4):83-91. PubMed ID: 20470789
[TBL] [Abstract][Full Text] [Related]
16. Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening.
Kloten V; Becker B; Winner K; Schrauder MG; Fasching PA; Anzeneder T; Veeck J; Hartmann A; Knüchel R; Dahl E
Breast Cancer Res; 2013 Jan; 15(1):R4. PubMed ID: 23320751
[TBL] [Abstract][Full Text] [Related]
17. RASSF1A and CDH1 hypermethylation as potential epimarkers in breast cancer.
Sebova K; Zmetakova I; Bella V; Kajo K; Stankovicova I; Kajabova V; Krivulcik T; Lasabova Z; Tomka M; Galbavy S; Fridrichova I
Cancer Biomark; 2011-2012; 10(1):13-26. PubMed ID: 22297548
[TBL] [Abstract][Full Text] [Related]
18. Detection of 14-3-3 sigma (σ) promoter methylation as a noninvasive biomarker using blood samples for breast cancer diagnosis.
Ye M; Huang T; Ying Y; Li J; Yang P; Ni C; Zhou C; Chen S
Oncotarget; 2017 Feb; 8(6):9230-9242. PubMed ID: 27999208
[TBL] [Abstract][Full Text] [Related]
19. Quantitative methylation-specific polymerase chain reaction gene patterns in urine sediment distinguish prostate cancer patients from control subjects.
Hoque MO; Topaloglu O; Begum S; Henrique R; Rosenbaum E; Van Criekinge W; Westra WH; Sidransky D
J Clin Oncol; 2005 Sep; 23(27):6569-75. PubMed ID: 16170165
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic alterations by methylation of RASSF1A and DAPK1 promoter sequences in mammary carcinoma detected in extracellular tumor DNA.
Ahmed IA; Pusch CM; Hamed T; Rashad H; Idris A; El-Fadle AA; Blin N
Cancer Genet Cytogenet; 2010 Jun; 199(2):96-100. PubMed ID: 20471512
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
